These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The history and contemporary challenges of the US Food and Drug Administration. Borchers AT, Hagie F, Keen CL, Gershwin ME. Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043 [Abstract] [Full Text] [Related]
4. Import for export; reporting and recordkeeping requirements for unapproved or violative products imported for further processing or incorporation and subsequent export--FDA. Proposed rule. Fed Regist; 1998 Nov 24; 63(226):64930-7. PubMed ID: 10338872 [Abstract] [Full Text] [Related]
6. Draft guidance for industry; exports and imports under the FDA Export Reform and Enhancement Act of 1996--FDA. Notice. Fed Regist; 1998 Jun 12; 63(113):32219-34. PubMed ID: 10180275 [Abstract] [Full Text] [Related]
7. Medical devices; humanitarian use of devices--FDA. Direct final rule. Fed Regist; 1998 Apr 17; 63(74):19185-90. PubMed ID: 10178430 [Abstract] [Full Text] [Related]
8. Medical device labeling and advertising: an overview. Basile EM, Armentrout E, Reeves KN. Food Drug Law J; 1999 Apr 17; 54(4):519-33. PubMed ID: 11824451 [Abstract] [Full Text] [Related]
10. Gastroenterology-urology devices; effective date of requirement for premarket approval of the penile inflatable implant. Food and Drug Administration, HHS. Final rule. Fed Regist; 2000 Apr 12; 65(71):19650-8. PubMed ID: 11010632 [Abstract] [Full Text] [Related]
12. Medical device reporting: manufacturer reporting, importer reporting, user facility reporting, and distributor reporting--FDA. Direct final rule. Fed Regist; 1998 May 12; 63(91):26069-77. PubMed ID: 10179334 [Abstract] [Full Text] [Related]
14. Medical devices; 30-day notices and 135-day PMA (premarket approval application) supplement review--FDA. Direct final rule. Fed Regist; 1998 Apr 27; 63(80 Pt 1):20530-3. PubMed ID: 10179319 [Abstract] [Full Text] [Related]
15. Investigational new drugs: export requirements for unapproved new drug products. Final rule. Food and Drug Administration, HHS. Fed Regist; 2005 Nov 23; 70(225):70720-30. PubMed ID: 16304736 [Abstract] [Full Text] [Related]
16. Guidance of FDA's expectations of medical device manufacturers concerning the year 2000 date problem--FDA. Notice. Fed Regist; 1998 Jun 24; 63(121):34433-42. PubMed ID: 10180297 [Abstract] [Full Text] [Related]
17. Medical devices; medical device reporting; baseline reports. Direct final rule. Food and Drug Administration, HHS. Fed Regist; 2008 Jun 13; 73(115):33692-5. PubMed ID: 18677824 [Abstract] [Full Text] [Related]
18. Medical devices; device tracking; new orders to manufacturers--FDA. Notice. Fed Regist; 1998 Mar 04; 63(42):10638-40. PubMed ID: 10177504 [Abstract] [Full Text] [Related]
19. FDA's expanding postmarket authority to monitor and publicize food and consumer health product risks: the need for procedural safeguards to reduce "transparency" policy harms in the post-9/11 regulatory environment. Roller ST, Pippins RR, Ngai JW. Food Drug Law J; 2009 Mar 04; 64(3):577-98. PubMed ID: 19999646 [Abstract] [Full Text] [Related]